Louise-laure Mariani

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications

Motor and non-motor symptoms of Parkinson's disease in the elderly population

Motor and non-motor symptoms of Parkinson's disease in the elderly population

Journal: Geriatrie et psychologie neuropsychiatrie du vieillissement
Published: February 02, 2026

Author Correction: Classification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysis.

Author Correction: Classification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysis.

Journal: NPJ Parkinson's disease
Published: November 21, 2025

Risk of Falls and Need of Walking Aid in Parkinson's Disease: Incidence and Impact of Comorbidities.

Risk of Falls and Need of Walking Aid in Parkinson's Disease: Incidence and Impact of Comorbidities.

Journal: Movement disorders clinical practice
Published: September 23, 2025

Modulation of striatal cAMP levels: A key pathway in the treatment of hyperkinetic movement disorders.

Modulation of striatal cAMP levels: A key pathway in the treatment of hyperkinetic movement disorders.

Journal: iScience
Published: July 30, 2025

Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK).

Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK).

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: July 17, 2025

Characterization of mice with cell type-specific Gnal loss of function provides insights on GNAL-linked dystonia.

Characterization of mice with cell type-specific Gnal loss of function provides insights on GNAL-linked dystonia.

Journal: Neurobiology of disease
Published: July 01, 2025

Motor and Non-motor Complications Following Different Early Therapies in Parkinson's Disease: Longitudinal Analysis of Real-Life Clinical and Therapeutic Data from the French NS-PARK Cohort.

Motor and Non-motor Complications Following Different Early Therapies in Parkinson's Disease: Longitudinal Analysis of Real-Life Clinical and Therapeutic Data from the French NS-PARK Cohort.

Journal: CNS drugs
Published: May 12, 2025

Broad transcriptomic effects of Egr1 knockdown in the mouse nucleus accumbens core and its role in cocaine locomotor sensitization.

Broad transcriptomic effects of Egr1 knockdown in the mouse nucleus accumbens core and its role in cocaine locomotor sensitization.

Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: April 02, 2025

AZP2006 in Progressive Supranuclear Palsy: Outcomes from a Phase 2a Multicenter, Randomized Trial, and Open-Label Extension on Safety, Biomarkers, and Disease Progression.

AZP2006 in Progressive Supranuclear Palsy: Outcomes from a Phase 2a Multicenter, Randomized Trial, and Open-Label Extension on Safety, Biomarkers, and Disease Progression.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: March 24, 2025

Classification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysis.

Classification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysis.

Journal: NPJ Parkinson's disease
Published: January 27, 2025

PYK2 in the dorsal striatum of Huntington's disease R6/2 mouse model.

PYK2 in the dorsal striatum of Huntington's disease R6/2 mouse model.

Journal: Neurobiology of disease
Published: January 19, 2025

Linking polygenic risk scores to dopaminergic neuron loss using neuromelanin-sensitive imaging.

Linking polygenic risk scores to dopaminergic neuron loss using neuromelanin-sensitive imaging.

Journal: Brain : a journal of neurology
Published: November 07, 2024
Showing 1-12 of 46

Last Updated: 09/26/2026